rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2010-1-12
|
pubmed:abstractText |
Imatinib, given concurrently or alternating with chemotherapy, has improved the response and survival of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph(+) ALL) but relapses are still frequent. The aim of this study was to evaluate the feasibility and results of giving imatinib concurrently with intensive chemotherapy, stem cell transplantation and post-transplant imatinib maintenance therapy in patients with newly diagnosed Ph(+) ALL.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-10653870,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-11237064,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-11258387,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-11861265,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-12094249,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-12586618,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-14551133,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-14562124,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-14562125,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-14576058,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-15315963,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-15334052,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-15657178,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-15817679,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-16034462,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-16219571,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-16344315,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-16638934,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-17062730,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-17119111,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-17405907,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-17429836,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-18986386,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-20065078,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797728-4793138
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1592-8721
|
pubmed:author |
pubmed-author:BernalMaria-TeresaMT,
pubmed-author:BrunetSalutS,
pubmed-author:BureoEncarnaE,
pubmed-author:Del PotroEloyE,
pubmed-author:EsteveJordiJ,
pubmed-author:GonzálezMarcosM,
pubmed-author:Grupo Español de Trasplante Hemopoyético Groups,
pubmed-author:Martín-ReinaVictoriaV,
pubmed-author:MorenoMaria-JoséMJ,
pubmed-author:OriolAlbertA,
pubmed-author:ParodyRicardoR,
pubmed-author:Programa Español de Tratamiento en Hematología,
pubmed-author:RiberaJosep-MariaJM,
pubmed-author:RivasConcepciónC,
pubmed-author:SarráJosepJ,
pubmed-author:TormoMarM,
pubmed-author:VidrialesBelénB,
pubmed-author:de OteyzaJaime PérezJP
|
pubmed:issnType |
Electronic
|
pubmed:volume |
95
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
87-95
|
pubmed:meshHeading |
pubmed-meshheading:19797728-Adolescent,
pubmed-meshheading:19797728-Adult,
pubmed-meshheading:19797728-Child,
pubmed-meshheading:19797728-Combined Modality Therapy,
pubmed-meshheading:19797728-Female,
pubmed-meshheading:19797728-Follow-Up Studies,
pubmed-meshheading:19797728-Humans,
pubmed-meshheading:19797728-Male,
pubmed-meshheading:19797728-Middle Aged,
pubmed-meshheading:19797728-Philadelphia Chromosome,
pubmed-meshheading:19797728-Piperazines,
pubmed-meshheading:19797728-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:19797728-Prospective Studies,
pubmed-meshheading:19797728-Pyrimidines,
pubmed-meshheading:19797728-Remission Induction,
pubmed-meshheading:19797728-Stem Cell Transplantation,
pubmed-meshheading:19797728-Survival Rate,
pubmed-meshheading:19797728-Treatment Outcome,
pubmed-meshheading:19797728-Young Adult
|
pubmed:year |
2010
|
pubmed:articleTitle |
Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial.
|
pubmed:affiliation |
Department of Hematology of the Hospitals Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Badalona, Spain. jribera@iconcologia.net
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|